Adalimumab induced interstitial lung disease

Tumor necrosis factor inhibitors have been implicated in many pulmonary complications. Before starting these class of drugs latent infection as tuberculosis and preexisting lung disease should be excluded. These agents have been linked to pulmonary nodules, pneumonitis, fibrosis, autoimmune reaction...

Descripción completa

Detalles Bibliográficos
Autores principales: Aqsa, Anum, Sharma, Dikshya, Chalhoub, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005541/
https://www.ncbi.nlm.nih.gov/pubmed/32055438
http://dx.doi.org/10.1016/j.rmcr.2020.101012
_version_ 1783494957492862976
author Aqsa, Anum
Sharma, Dikshya
Chalhoub, Michel
author_facet Aqsa, Anum
Sharma, Dikshya
Chalhoub, Michel
author_sort Aqsa, Anum
collection PubMed
description Tumor necrosis factor inhibitors have been implicated in many pulmonary complications. Before starting these class of drugs latent infection as tuberculosis and preexisting lung disease should be excluded. These agents have been linked to pulmonary nodules, pneumonitis, fibrosis, autoimmune reactions and infection. We report a case of adalimumab induced organizing pneumonia in an old gentleman who was started on the drug for his uncontrolled Psoriasis.
format Online
Article
Text
id pubmed-7005541
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-70055412020-02-13 Adalimumab induced interstitial lung disease Aqsa, Anum Sharma, Dikshya Chalhoub, Michel Respir Med Case Rep Case Report Tumor necrosis factor inhibitors have been implicated in many pulmonary complications. Before starting these class of drugs latent infection as tuberculosis and preexisting lung disease should be excluded. These agents have been linked to pulmonary nodules, pneumonitis, fibrosis, autoimmune reactions and infection. We report a case of adalimumab induced organizing pneumonia in an old gentleman who was started on the drug for his uncontrolled Psoriasis. Elsevier 2020-02-01 /pmc/articles/PMC7005541/ /pubmed/32055438 http://dx.doi.org/10.1016/j.rmcr.2020.101012 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Aqsa, Anum
Sharma, Dikshya
Chalhoub, Michel
Adalimumab induced interstitial lung disease
title Adalimumab induced interstitial lung disease
title_full Adalimumab induced interstitial lung disease
title_fullStr Adalimumab induced interstitial lung disease
title_full_unstemmed Adalimumab induced interstitial lung disease
title_short Adalimumab induced interstitial lung disease
title_sort adalimumab induced interstitial lung disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005541/
https://www.ncbi.nlm.nih.gov/pubmed/32055438
http://dx.doi.org/10.1016/j.rmcr.2020.101012
work_keys_str_mv AT aqsaanum adalimumabinducedinterstitiallungdisease
AT sharmadikshya adalimumabinducedinterstitiallungdisease
AT chalhoubmichel adalimumabinducedinterstitiallungdisease

Ejemplares similares